Only three other studies have studied the differential expression of miRNAs in histological subtypes of endometrial carcinoma, and only one has compared the differential expression of miRNAs in MMR-deficient vs. MMR-intact cancers [28,29,30]. This evidence concerns the gene MRC1 and endometrial carcinoma.